Hsbc Holdings PLC raised its holdings in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) by 31.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 83,350 shares of the company’s stock after purchasing an additional 19,788 shares during the period. Hsbc Holdings PLC owned approximately 0.05% of Envista worth $1,821,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares in the last quarter. Allworth Financial LP increased its holdings in Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares in the last quarter. UMB Bank n.a. raised its position in Envista by 46.1% in the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares during the last quarter. Finally, IFP Advisors Inc boosted its holdings in shares of Envista by 102.9% during the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares during the last quarter.
Envista Stock Performance
Shares of NYSE NVST traded up $0.19 during midday trading on Friday, hitting $25.95. 3,757,959 shares of the company’s stock traded hands, compared to its average volume of 2,444,100. The firm has a fifty day moving average of $24.84 and a 200 day moving average of $25.42. Envista Holdings Corporation has a 1 year low of $18.77 and a 1 year high of $30.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. The stock has a market capitalization of $4.22 billion, a price-to-earnings ratio of 63.30, a price-to-earnings-growth ratio of 1.47 and a beta of 0.86.
Analyst Upgrades and Downgrades
NVST has been the subject of several research reports. Barclays decreased their price objective on shares of Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, June 11th. Robert W. Baird raised their target price on shares of Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Morgan Stanley lifted their target price on shares of Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, April 24th. Weiss Ratings lowered shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Finally, JPMorgan Chase & Co. increased their price target on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $28.54.
View Our Latest Research Report on NVST
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Read More
- Five stocks we like better than Envista
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
- Why “Big Short” Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
